News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • OpenAI launches GPT-6 Astra, calling it its most capable model while flagging rising human oversight and control challenges.
  • Zscaler reports fiscal Q4 and 2026 results with 25% revenue and ARR growth and projects continued double-digit fiscal 2027 growth.
  • Ambarella posts Q2 revenue up 13.2% to $108.1 million and reports improved non-GAAP net income.
  • Ambarella inks a long-term distribution deal with Macnica and hires Capgemini to accelerate edge and Physical AI adoption.
  • DocuSign shares rally over 8% after Q2 results beat estimates and the company raised its ARR growth target on AI momentum.
  • Concrete Pumping Holdings posts Q3 revenue up 13% to $116.8 million and initiates a quarterly cash dividend yielding 5.6%.
  • Donald Trump says Britain is 'on the edge of disaster,' faulting energy policy and migration and renewing criticism of the UK government.

Latest Articles

Rocket Lab: A Deep-Value Growth Trade Beyond Neutron's Launch

Rocket Lab: A Deep-Value Growth Trade Beyond Neutron's Launch

Rocket Lab's valuation is anchored to Neutron, but the business has already scaled into larger, recurring revenue streams: record backlog (~$2.36B), a $397M Space Force contract, healthy Electron cadence and growing Space Systems revenue. This trade idea buys that structural growth while respecting high execution risk and a still-rich valuation.

Anthropic Commits $45 Billion to Nscale for West Virginia AI Cloud Capacity

Anthropic Commits $45 Billion to Nscale for West Virginia AI Cloud Capacity

Anthropic PBC has struck a binding commitment to lease $45 billion of cloud computing capacity from Nscale's Monarch campus in West Virginia. The six-year deal covers roughly 460 megawatts of power and will be served by Nvidia Vera Rubin chips coming online beginning late next year, according to the report. The agreement is part of a series of larg…

S&P Revises TTM Technologies Outlook to Stable After $1.1 Billion Epiq Deal

S&P Revises TTM Technologies Outlook to Stable After $1.1 Billion Epiq Deal

S&P Global Ratings downgraded its outlook on TTM Technologies to stable from positive while maintaining the company's 'BB' issuer credit rating after TTM announced a $1.1 billion acquisition of Epiq Solutions. The agency expects the purchase will be financed with debt, lifting pro forma leverage into the high-2x area when the transaction closes in …

What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work

What Underwear Should You Buy for Fall? Duluth Trading Shares First-Layer Essentials for Back to Campus and Back to Work

Duluth Trading Co. highlights the importance of upgrading underwear as a foundational wardrobe piece for fall, focusing on comfort, moisture-wicking, and fit for both men and women. With a record $146.8 billion anticipated for back-to-school spending in 2026, Duluth encourages consumers to consider performance-driven first-layer apparel from its Bu…

Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

Cycurion, Inc. announces a 1-for-8 reverse stock split to meet NASDAQ listing requirements, backed by significant improvements including expanded gross margins, reduced net debt by over 50%, completion of two acquisitions, and a 10-year $54.6 million contract with HHS. The company targets break-even profitability by Q2 2027 and is confident in its …

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Revolution Medicines announced FDA approval of RASONQUE (daraxonrasib), an oral, broad-spectrum RAS inhibitor for adults with metastatic pancreatic adenocarcinoma who have received prior systemic therapy or are ineligible for multiagent therapy. The approval, based on the positive Phase 3 RASolute 302 trial results showing a 60% reduction in risk o…

Garden Grove Clarity Helps, But Melrose Still Has Work to Do

Garden Grove Clarity Helps, But Melrose Still Has Work to Do

Melrose's announcement around the Garden Grove asset removes a key overhang and should give the stock some breathing room. That said, execution on integration, cash conversion and debt reduction remains the dominant driver for returns. This trade idea sizes a tactical long with clearly defined entry, stop and target framed around the remaining exec…

KNDS Prepares to Reopen Investor Roadshow as Defense Stocks Recover

KNDS Prepares to Reopen Investor Roadshow as Defense Stocks Recover

KNDS NV is resuming investor engagement about a possible initial public offering this year after earlier plans were paused amid a downturn in defense stocks. The company is planning investor update meetings next week and is exploring a relaunch of the IPO process as soon as the second half of September, though the timeline remains subject to feedba…

Morgan Stanley Says Thai Refiners Set to Significantly Lift Dividend Payouts

Morgan Stanley Says Thai Refiners Set to Significantly Lift Dividend Payouts

Morgan Stanley projects Thai oil refiners will sharply boost shareholder distributions, noting a twofold increase has already occurred and forecasting a threefold rise in 2026. The bank links the outlook to stronger cash generation from elevated margins, reduced debt loads and moderated capital spending, while pointing to tight product markets driv…

Qifu Technology Shares Fall Sharply After Multiple Broker Downgrades

Qifu Technology Shares Fall Sharply After Multiple Broker Downgrades

Qifu Technology (NASDAQ:QFIN) fell 17.9% on Wednesday after several Wall Street analysts downgraded the stock and lowered price targets, following second-quarter results that missed estimates and third-quarter guidance that came in below consensus. Analysts pointed to industry liquidity and credit collection pressures, lower-than-expected loan volu…

EQT: Buy the Structural Gas Story at a Reasonable Price

EQT: Buy the Structural Gas Story at a Reasonable Price

EQT offers a long-term buy opportunity driven by durable demand for U.S. natural gas, a clean balance sheet, and attractive valuation metrics. With a market cap near $34.5B, a P/E around 12.5 and free cash flow of roughly $3.76B, the stock provides a disciplined way to play secular tailwinds like LNG exports, data center gas demand, and infrastruct…